Spectrum Pharmaceuticals, Inc (NASDAQ:SPPI) has lately been going through difficult times. The most tragic point was when the biopharma pronounced the failure of the drugs in the Phase II trial. These had been targeted towards the treatment of very severe lung cancer. The test confirmed that the drug did not meet the required endpoint, something […]
Sign Up To Get Our Instant Alerts!
- Japanese Premier Declares COVID-19 State of Emergency in Tokyo 116 views
- Buscar Company has completed the acquisition of APTG Inc., a Solar Concentrated Power technology company 75 views
- Google Gives Spotify its Own In-App Payment Option as Part of a New Pilot 66 views
- Toyota Suspends Production at 2 Plants in Japan Citing Chip Shortage 62 views
- China Unveils Maglev Train With a Top Speed of 600 kph 46 views